80111-48-4

Basic information

• Product Name: L-Alanine, N-(cyclohexylcarbonyl)-, 11-ester with 20,23-didehydro-20,2 3-dideoxo-20,23-dihydroxyansatrienol A
• Synonyms: L-Alanine, N-(cyclohexylcarbonyl)-, 11-ester with 20,23-didehydro-20,2 3-dideoxo-20,23-dihydroxyansatrienol A
• CAS NO: 80111-48-4
• Molecular Formula: C36H50N2O8
• Molecular Weight: 638.797
• Mol File: 80111-48-4.mol

Chemical Properties

• Boiling Point: 834.5°C at 760 mmHg
• Flash Point: 458.5°C
• Appearance: /
• Density: 1.21g/cm³
• Vapor Pressure: 1.54E-29mmHg at 25°C
• Refractive Index: 1.588
• CAS DataBase Reference: L-Alanine, N-(cyclohexylcarbonyl)-, 11-ester with 20,23-didehydro-20,2 3-dideoxo-20,23-dihydroxyansatrienol A(CAS DataBase Reference)
• NIST Chemistry Reference: L-Alanine, N-(cyclohexylcarbonyl)-, 11-ester with 20,23-didehydro-20,2 3-dideoxo-20,23-dihydroxyansatrienol A(80111-48-4)
• EPA Substance Registry System: L-Alanine, N-(cyclohexylcarbonyl)-, 11-ester with 20,23-didehydro-20,2 3-dideoxo-20,23-dihydroxyansatrienol A(80111-48-4)

Safety Data

• Hazardous Substances Data: 80111-48-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C36H50N2O8/c1-23-14-13-17-27-20-28(39)21-30(34(27)42)38-32(40)22-29(45-4)18-11-6-5-7-12-19-31(24(2)33(23)41)46-36(44)25(3)37-35(43)26-15-9-8-10-16-26/h5-7,11-12,14,18,20-21,24-26,29,31,33,39,41-42H,8-10,13,15-17,19,22H2,1-4H3,(H,37,43)(H,38,40)/b6-5+,12-7+,18-11-,23-14-/t24-,25+,29-,31-,33-/m0/s1

Upstream product

• 82189-03-5 (+)-mycotrienin I 
• 98873-83-7 (+)-trienomycin A 
• 82189-03-5 (+)-mycotrienin I 
• 117543-72-3 (+)-trienomycinol 
• 100662-00-8 (+)-trienomycin C 
• 98873-83-7 (+)-trienomycin A 
• 134861-32-8 (6E,8E,10E,16Z)-(5R,13S,14S,15R)-22-(tert-Butyl-dimethyl-silanyloxy)-13,15-dihydroxy-5-methoxy-14,16-dimethyl-2-aza-bicyclo[18.3.1]tetracosa-1⁽²⁴⁾,6,8,10,16,20,22-heptaen-3-one 
• 180628-68-6 (R)-2-(Cyclohexanecarbonyl-amino)-propionic acid (6E,8E,10E,16Z)-(5R,13S,14R,15R)-22-(tert-butyl-dimethyl-silanyloxy)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-aza-bicyclo[18.3.1]tetracosa-1⁽²⁴⁾,6,8,10,16,20,22-heptaen-13-yl ester 
• 180628-67-5 (R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-propionic acid (6E,8E,10E,16Z)-(5R,13S,14R,15R)-22-(tert-butyl-dimethyl-silanyloxy)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-aza-bicyclo[18.3.1]tetracosa-1⁽²⁴⁾,6,8,10,16,20,22-heptaen-13-yl ester 
• 171013-73-3 (4Z,12E,14E,16E)-(6R,10S,18R,27S)-24-(tert-Butyl-dimethyl-silanyloxy)-18-methoxy-5,8,8,27-tetramethyl-7,9-dioxa-21-aza-tricyclo[20.3.1.1^6,10]heptacosa-1⁽²⁵⁾,4,12,14,16,22⁽²⁶⁾,23-heptaen-20-one 
• 100662-01-9 trienomycin B 
• 98-89-5 Cyclohexanecarboxylic acid 
• 82189-03-5 ansatrienin A 

Relevant articles and documents

Ansamycin antibiotics as free radical scavengers isolated from Streptomyces by using the bactericidal action of the hydroxyl radical

Ansamycin antibiotics (1-4) were isolated from the cultured broth of Streptomyces sp. USF-319 strain as a result of our screening for free radical scavengers. They inhibited the bactericidal effect of the Fenton reagent toward Bacillus subtilis by their radical scavenging activity. Some of them also showed inhibitory activity against lipid peroxidation and lipoxygenases.

New ansamycin derivatives generated by simultaneous mutasynthesis

The conversion from triene- to diene-typed ansamycins is clarified step by step in Streptomyces seoulensis IFB-A01. Such an intertype convertibility is adopted to establish for the first time the simultaneous mutasynthesis of both types of C17-benzene ans

(+)-Mycotrienins I and II: Relative and absolute stereochemistry

The complete relative and absolute stereochemistry of the potent antifungal antibiotics (+)-mycotrienin I and (+)-mycotrienin II have been established by chemical correlation with the antitumor agent (+)-trienomycin A.

(+)-Trienomycins A, B, C, and F and (+)-mycotrienins I and II: Relative and absolute stereochemistry

The complete relative and absolute stereochemistries have been elucidated for the ansamycin antibiotics (+)-trienomycins A, B, and C and their potent antifungal congeners, the (+)-mycotrienins I and II. A new species, (+)-trienomycin F, has also been isol